Yaming Xi
Impact in
-
- Mesenchymal stem cell research
-
- Acute Myeloid Leukemia Research
Papers in
-
- Histone Deacetylase Inhibitors Research 4
- Epigenetics and DNA Methylation 4
- Retinoids in leukemia and cellular processes 3
- RNA modifications and cancer 3
- Hematology 13
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 4
- Hemophilia Treatment and Research 3
- Co-authors
- Zijian Li (13 shared papers)Ting Liu (3 shared papers)Ling Gu (1 shared paper)Shengfu Li (1 shared paper)Wentong Meng (1 shared paper)Che Chen (3 shared papers)Yongmei Liu (2 shared papers)Huanling Zhu (2 shared papers)
- Journals
- Medicine (4 papers)Bioscience Reports (2 papers)Haemophilia (2 papers)Anti-Cancer Drugs (2 papers)Neoplasia (1 paper)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Yaming Xi
38 papers receiving 179 citations
Peers
Comparison fields: 5 of 58
- Genetics 44
- Hematology 40
- Cancer Research 30
- Molecular Biology 97
- Immunology 26
Countries citing papers authored by Yaming Xi
This map shows the geographic impact of Yaming Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaming Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaming Xi more than expected).
Fields of papers citing papers by Yaming Xi
This network shows the impact of papers produced by Yaming Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaming Xi. The network helps show where Yaming Xi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaming Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 36 | |
| 2 | 2019 | 16 | |
| 3 | 2011 | 16 | |
| 4 | 2007 | 16 | |
| 5 | 2023 | 12 | |
| 6 | 2021 | 9 | |
| 7 | 2025 | 5 | |
| 8 | 2019 | 5 | |
| 9 | [Relationship of MPO and NQO1 gene polymorphisms with susceptibility to acute leukemia]. | 2012 | 5 |
| 10 | 2021 | 5 | |
| 11 | [Effects of AZT on leukemia cell line KG-1a proliferation and telomerase activity]. | 2012 | 5 |
| 12 | 2024 | 4 | |
| 13 | 2019 | 4 | |
| 14 | 2019 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2025 | 3 | |
| 19 | [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs]. | 2007 | 3 |
| 20 | [Relation of GSTP1 and CYP2E1 polymorphisms with susceptibility to acute leukemia]. | 2011 | 3 |
About Yaming Xi
Yaming Xi is a scholar working on Molecular Biology, Hematology, Genetics, Oncology and Immunology, having authored 44 papers that have together received 183 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Histone Deacetylase Inhibitors Research (4 papers), Epigenetics and DNA Methylation (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Retinoids in leukemia and cellular processes (3 papers), RNA modifications and cancer (3 papers) and Hemophilia Treatment and Research (3 papers). The work is most often cited by research in Genetics (44 citations), Hematology (40 citations), Cancer Research (30 citations), Molecular Biology (97 citations) and Immunology (26 citations). Yaming Xi has collaborated with scholars based in China, France and United States. Frequent co-authors include Zijian Li, Ting Liu, Ling Gu, Shengfu Li, Wentong Meng, Che Chen, Yongmei Liu, Huanling Zhu, Xiaoxi Lu and Zhao Li. Their work appears in journals such as Medicine, Bioscience Reports, Haemophilia, Anti-Cancer Drugs and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.